These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inventions designed to enhance drug delivery across epithelial and endothelial cells through the paracellular pathway. Gonzalez-Mariscal L, Hernández S, Vega J. Recent Pat Drug Deliv Formul; 2008; 2(2):145-76. PubMed ID: 19075905 [Abstract] [Full Text] [Related]
3. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Deli MA. Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815 [Abstract] [Full Text] [Related]
4. Strategies that Target Tight Junctions for Enhanced Drug Delivery. González-Mariscal L, Posadas Y, Miranda J, Uc PY, Ortega-Olvera JM, Hernández S. Curr Pharm Des; 2016 Apr; 22(35):5313-5346. PubMed ID: 27510485 [Abstract] [Full Text] [Related]
5. Molecular mechanism of intestinal permeability: interaction at tight junctions. Hossain Z, Hirata T. Mol Biosyst; 2008 Dec; 4(12):1181-5. PubMed ID: 19396381 [Abstract] [Full Text] [Related]
10. Targeting tight junction proteins-significance for drug development. Kondoh M, Yoshida T, Kakutani H, Yagi K. Drug Discov Today; 2008 Feb; 13(3-4):180-6. PubMed ID: 18275916 [Abstract] [Full Text] [Related]
11. The tight junction: morphology to molecules. Stevenson BR, Keon BH. Annu Rev Cell Dev Biol; 1998 Feb; 14():89-109. PubMed ID: 9891779 [Abstract] [Full Text] [Related]
12. Pathological changes in tight junctions and potential applications into therapies. Takahashi A, Kondoh M, Suzuki H, Watari A, Yagi K. Drug Discov Today; 2012 Jul; 17(13-14):727-32. PubMed ID: 22414542 [Abstract] [Full Text] [Related]
14. Aldosterone and tight junctions: modulation of claudin-4 phosphorylation in renal collecting duct cells. Le Moellic C, Boulkroun S, González-Nunez D, Dublineau I, Cluzeaud F, Fay M, Blot-Chabaud M, Farman N. Am J Physiol Cell Physiol; 2005 Dec 04; 289(6):C1513-21. PubMed ID: 16107502 [Abstract] [Full Text] [Related]
15. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. Nava P, López S, Arias CF, Islas S, González-Mariscal L. J Cell Sci; 2004 Nov 01; 117(Pt 23):5509-19. PubMed ID: 15494377 [Abstract] [Full Text] [Related]
16. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N, Li N, Li Y, Xu G, Li J. Clin Immunol; 2008 Jan 01; 126(1):67-80. PubMed ID: 17964857 [Abstract] [Full Text] [Related]
17. Tight junction-based epithelial microenvironment and cell proliferation. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S. Oncogene; 2008 Nov 24; 27(55):6930-8. PubMed ID: 19029935 [Abstract] [Full Text] [Related]
18. Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization. Mullin JM, Soler AP, Laughlin KV, Kampherstein JA, Russo LM, Saladik DT, George K, Shurina RD, O'Brien TG. Exp Cell Res; 1996 Aug 25; 227(1):12-22. PubMed ID: 8806446 [Abstract] [Full Text] [Related]